Rochester Clinical Research Partners with Rochester Hope to Uplift the Community
RCR announces partnership with a local non-profit called Rochester Hope [Rochester, New York] — Rochester Clinical Research (RCR) has announced its partnership with Rochester Hope, a non-profit organization dedicated to providing vital services and support to the local community. This collaboration represents a powerful commitment to making a positive impact on the lives of Rochester […]
Read More
A Shot at Double Protection: Join Our COVID & Flu Vaccine Trial!
In the ongoing battle against infectious diseases, one thing is for certain: a strong immune system is your best defense. Now, imagine a world where you can bolster your defenses against both COVID-19 and the flu with a single shot. Well, that world might be closer than you think. A Dual Defense Strategy As healthcare […]
Read More
Antibody to Safeguard Infants from RSV Receives FDA Approval
Respiratory Syncytial Virus, commonly referred to as RSV, has been making headlines more frequently than ever before. This highly contagious virus targets the respiratory system, particularly the lungs, and typically presents cold-like symptoms. Among its most vulnerable victims are infants, for several crucial reasons. Their delicate immune systems, smaller airways, increased susceptibility, and heightened risk […]
Read More
A Phase 3 Smoking Cessation Study That RCR Worked On Shows Cytisinicline Is Well Tolerated and Effective In Helping People Quit
Rochester Clinical Research takes pride in its involvement in a phase 3 smoking cessation study, which has yielded promising and effective results in participants. The study aimed to assess the efficacy of Cytisinicline, a natural alkaloid present in various plant species that mimics nicotine’s effects in the brain, in promoting nicotine abstinence. Cytisinicline aids in […]
Read More
Rochester Clinical Research (RCR) Supports the Rochester Puerto Rican Festival, Offers Ticket Giveaway
FOR IMMEDIATE RELEASE Rochester Clinical Research (RCR) Supports the Rochester Puerto Rican Festival, Offers Ticket Giveaway Enter for a chance to win free tickets to Rochester’s 53rd Annual Puerto Rican Festival ROCHESTER, NY – Rochester Clinical Research (RCR) is excited to announce its sponsorship and participation in the highly-anticipated Rochester Puerto Rican Festival, taking place […]
Read More
Rochester Clinical Research to Support 25th Annual Saint’s Place Super Sale
Rochester Clinical Research staff to volunteer at four-day “Welcoming the Stranger” fundraiser helping thousands of Rochester-area refugees.
Read More
Mrs. Kasha Davis to Speak at Rochester Clinical Research Allyship Lunch & Learn
Popular local drag performer will speak about diversity and inclusion at a special Pride event on Thursday June 29th. Rochester Clinical Research (RCR), announced that Mrs. Kasha Davis, a popular drag queen, actor and television personality is scheduled to speak at the “RCR Allyship Lunch & Learn” on Thursday June 29th, from 12pm-1pm. Davis is […]
Read More
Rochester Clinical Research Wins “Best Clinical Trial Site Company” At The 2023 World Vaccine Congress Awards!
Rochester Clinical Research is thrilled to announce that we have been awarded the Vaccine Industry Excellence (VIE) award for “Best Clinical Trial Site Company” at the 2023 World Vaccine Congress, which took place on April 4th in Washington, D.C. The VIE Awards is an annual event that celebrates the outstanding achievements made globally by clinical […]
Read More
RCR Helps Acute Migraine Nasal Spray Get FDA Approved
Rochester Clinical Research takes great pride in its contribution to Pfizer’s groundbreaking study on Zavzpret (zavegepant) migraine nasal spray, which has recently received FDA approval. This innovative treatment is the first of its kind designed to treat acute migraines in adults by acting as a calcitonin gene-related peptide (CGRP) receptor antagonist, effectively inhibiting CGRP from […]
Read More
RCR’s, Dr. Matthew Davis, on Channel 10 News talking about our pediatric Lyme Disease study
Doctors working to develop a vaccine for Lyme Disease Patrick Moussignac News10NBCApril 26, 2023 – 5:56 PM ROCHESTER, N.Y. – Lyme disease is one of the most common diseases transmitted by an insect bite. Doctors say it’s prevalent here in western New York, and no one is immune. There are also no vaccines for it. Rochester […]
Read More